Beijing-Gansu Top Experts Gather in Jinchang to Build Cancer Diagnosis & Treatment Hub

Top Beijing and Gansu Specialists Gather in Jinchang to Build a New Highland in Cancer Diagnosis and Treatment

Recently, Professor Fang Hong from the Department of Medical Oncology and Chemotherapy at Peking University First Hospital, Professor Zheng Jiasheng from the Department of Minimally Invasive Oncology at Peking University International Hospital, and Professor Xie Dan, Secretary-General of the National Strategic Alliance for Technological Innovation in the Tumor Minimally Invasive Treatment Industry, visited the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital. Centered on the core theme of "Collaborative Integration of Minimally Invasive Tumor Therapy and Heavy Ion Radiotherapy," they conducted in-depth academic exchanges and provided technical guidance. This initiative injects high-level expertise and innovative momentum into the cause of precise cancer treatment in Northwest China and even the whole country, helping to elevate the "Healthy Gansu" initiative to new heights.

As a senior expert in the field of medical oncology, Professor Fang Hong has been deeply engaged in clinical frontline work for over thirty years . With solid academic attainments and extensive diagnostic experience, she collaborated with Dr. Zhao Yuliang to establish the hospital's chemotherapy ward, laying an important foundation for the department's standardized construction and the improvement of its diagnosis and treatment system . She is proficient in the personalized treatment of various solid tumors, including urinary system tumors, lung cancer, and breast cancer . She innovatively proposed the integrated service concept of "Treatment + Care," ensuring precise treatment while also addressing comprehensive patient care dimensions such as nutritional support, pain intervention, palliative care, and TCM recuperation, truly achieving whole-process humanistic care for cancer patients.

During ward rounds, Professor Fang Hong worked closely with the center's medical team to conduct case studies . She meticulously analyzed patient imaging data case by case, traced the development of conditions, and dynamically optimized treatment plans based on international frontline diagnostic standards, allowing patients in Northwest China to access quality medical services synchronized with international practices right at their doorstep.

Professor Zheng Jiasheng, founder of the National Alliance for Tumor Minimally Invasive Treatment and Chief Expert of the Minimally Invasive Tumor Center at Beijing You'an Hospital affiliated with Capital Medical University, has decades of experience in the field of minimally invasive oncology . He is not only a leader in discipline construction but also a promoter of standardized development within the industry . He spearheaded the creation of an MDT diagnosis and treatment center for liver cancer and the Beijing Integrated Traditional Chinese and Western Medicine Minimally Invasive Tumor Center, guiding the popularization and standardization of minimally invasive tumor diagnosis and treatment technologies with innovative thinking.

During the symposium, Professor Zheng, based on industry development trends, proposed the humanistic treatment concept of "Minimally Invasive, Scar-Free Healing" . He emphasized that building China's minimally invasive tumor diagnosis and treatment system and the medical prevention system requires concerted efforts from industry colleagues . He stated that the Alliance is willing to reach a strategic collaboration with Gansu Wuwei Cancer Hospital to jointly create a full-chain management model for cancer encompassing "Prevention, Control, Diagnosis, Treatment, and Rehabilitation," promote deep multi-disciplinary integration, achieve resource co-construction, sharing, and mutual benefit, and empower the high-quality development of tumor diagnosis and treatment.

Professor Xie Dan, leveraging her deep insights accumulated over years in the healthcare industry and an international perspective, possesses exceptional strategic planning, management operation, and resource integration capabilities, particularly with profound attainments in capital operation . Holding multiple positions including Vice President of the Beijing Medical Association Radiological Interventional Specialist Physician Branch and Director of the Shanghai Cooperation Organization Medical Office, she possesses the strength for cross-platform and cross-domain coordination, serving as an important link connecting industrial resources with medical practice, and international experience with industry development.

During the symposium, Secretary-General Xie Dan detailed the Alliance's achievements in supporting the development of minimally invasive oncology disciplines in hospitals at all levels . She indicated that the Alliance would utilize professional, standardized talent training systems and quality control standards to comprehensively help enhance the center's comprehensive service capacity and operational efficiency, promote the flow of quality medical resources to regional centers, and support regional medical collaborative development.

For a long time, Gansu Wuwei Cancer Hospital has consistently adhered to its mission of "Gathering Global Cutting-Edge Technologies for the Benefit of All Cancer Patients," aiming to build an international first-class platform for cancer diagnosis and treatment by continuously absorbing top global medical expertise . The hospital has successively invited international authoritative experts for technical exchanges, promoting the alignment of Chinese diagnostic standards with international norms . Recently, it has further introduced professors for long-term residency work, deeply integrating Chinese standards into clinical teaching and technical guidance, laying a solid foundation for building an internationally competitive cancer treatment system and standard export platform . This deep collaboration between Beijing and Gansu experts represents another important practice of the hospital's talent strategy, building a high-quality bridge for the efficient integration of top technology and local resources.

In the future, the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital will continue to rely on the characteristic technical advantages of heavy ion therapy, deepen collaboration with renowned experts from top domestic and international cancer diagnosis and treatment centers, improve regular expert working mechanisms, and promote the deep integration of advanced diagnosis and treatment concepts with local clinical practice . This will achieve synergistic development in clinical diagnosis/treatment, scientific research innovation, and talent cultivation . The hospital will steadily advance towards the goal of building an internationally influential hub for heavy ion tumor diagnosis and treatment, bringing new hope to cancer patients nationwide and globally with more precise treatment plans and higher-quality medical services, contributing solid strength to the "Healthy China" and "Healthy Gansu" initiatives.